Prot #I8F-MC-GPIT: A Phase 2, Randomized, Double-blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Investigational Tirzepatide Doses in Participants with Type 2 Diabetes and Obesity

Project: Research project

Project Details

StatusActive
Effective start/end date5/8/24 → 5/8/27

Funding

  • Lilly USA, LLC (Prot #I8F-MC-GPIT)